Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study

BACKGROUND: The optimal anticoagulant for end-stage renal disease patients for stroke prophylaxis is unknown. The efficacy and safety of warfarin in this population are debatable. In addition, real-world evidence of direct oral anticoagulants in patients with end-stage renal disease is limited. The...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Lin, Yi-Cheng, Chen, Bi-Li, Shih, Chun-Ming, Lin, Feng-Yen, Chen, Chih-Wei, Hsu, Chien-Yi, Kao, Yung-Ta, Bi, Wei-Fung, Chen, Li-Ying, Chien, Li-Nien, Fang, Te-Chao, Huang, Chun-Yao
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031437/
https://ncbi.nlm.nih.gov/pubmed/33831130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0249940
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky